240 related articles for article (PubMed ID: 31468119)
1. Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.
Atef Y; Koedam TW; van Oostendorp SE; Bonjer HJ; Wijsmuller AR; Tuynman JB
World J Surg; 2019 Dec; 43(12):3198-3206. PubMed ID: 31468119
[TBL] [Abstract][Full Text] [Related]
2. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
3. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
4. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
[TBL] [Abstract][Full Text] [Related]
6. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
Law BZY; Yusuf Z; Ng YE; Aly EH
Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
[TBL] [Abstract][Full Text] [Related]
7. Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging.
Otowa Y; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
Onco Targets Ther; 2015; 8():3169-73. PubMed ID: 26604786
[TBL] [Abstract][Full Text] [Related]
8. Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida JI; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Yamamoto M; Sugihara K; Watanabe T
Int J Colorectal Dis; 2017 Oct; 32(10):1479-1487. PubMed ID: 28762189
[TBL] [Abstract][Full Text] [Related]
9. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
[TBL] [Abstract][Full Text] [Related]
10. What is the role of lateral lymph node dissection in rectal cancer patients with clinically suspected lateral lymph node metastasis after preoperative chemoradiotherapy? A meta-analysis and systematic review.
Yang X; Yang S; Hu T; Gu C; Wei M; Deng X; Wang Z; Zhou Z
Cancer Med; 2020 Jul; 9(13):4477-4489. PubMed ID: 32352659
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
[TBL] [Abstract][Full Text] [Related]
12. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
[TBL] [Abstract][Full Text] [Related]
13. [The Outcome of Preoperative Chemoradiotherapy for Advanced Lower Rectal Cancer-The Possibility of an Omission of the Lateral Dissection].
Hatano S; Kumakura M; Muta Y; Ito T; Chikatani K; Suzuki O; Toyomasu Y; Muramatsu S; Amano K; Ishiguro T; Kumagai Y; Ishibashi K; Inokuma S; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2019 Dec; 46(13):1957-1959. PubMed ID: 32157025
[TBL] [Abstract][Full Text] [Related]
14. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
16. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
18. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
19. Identification of patient subgroups with low risk of postoperative local recurrence for whom total mesorectal excision surgery alone is sufficient: a multicenter retrospective analysis.
Yamamoto T; Kawada K; Matsusue R; Kato S; Itatani Y; Hida K; Machimoto T; Yamaguchi T; Obama K
Int J Colorectal Dis; 2022 Oct; 37(10):2207-2218. PubMed ID: 36156129
[TBL] [Abstract][Full Text] [Related]
20. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
